Corbus Pharmaceuticals (CRBP) closed the last trading session at $6.03, gaining 0.5% over the past four weeks, but there ...

Exiger warns the U.S. is overly reliant on foreign countries to make key components of crucial medications as the Trump ...

In his first major action on health care costs this term, President Donald Trump issued a multi-part executive order on ...

An investigation into the national security implications of pharma imports has been underway for two weeks, the Trump ...

MIRA Pharmaceuticals (MIRA) announced data demonstrating the efficacy of the oral ketamine analog, Ketamir-2, in a validated animal model of ...

The Trump administration has taken its next steps toward imposing more tariffs on key imports, launching investigations into ...

The Trump administration initiated investigations into computer chips, semiconductor equipment, and pharmaceuticals imports ...

UnitedHealth has traditionally been a company investors saw as reliable, having not missed earnings estimates since the 2008 global financial crisis.

Pharmaceuticals are currently exempt from a baseline 10 per cent tax Mr Trump has placed on goods entering the US, but the US ...

The Washington Capitals announced today ALL CAPS 2025 Playoffs initiatives presented by Vanda Pharmaceuticals Inc.